Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now?
Is Catalyst Pharmaceuticals (CPRX) Stock Undervalued Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Are Investors Undervaluing Galiano Gold (GAU) Right Now?
Are Investors Undervaluing Galiano Gold (GAU) Right Now?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Oils-Energy Stocks Lagging  Marathon Petroleum (MPC) This Year?
Are Oils-Energy Stocks Lagging Marathon Petroleum (MPC) This Year?

For those looking to find strong Oils-Energy stocks, it is prudent to search for companies in the group that are outperforming their peers. Marathon Petroleum (MPC) is a stock that can certainly

Should Value Investors Buy Travel  Leisure Co. (TNL) Stock?
Should Value Investors Buy Travel Leisure Co. (TNL) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the

Is Assurant (AIZ) Stock Undervalued Right Now?
Is Assurant (AIZ) Stock Undervalued Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Are Transportation Stocks Lagging  Pony AI Inc. - Sponsored ADR (PONY) This Year?
Are Transportation Stocks Lagging Pony AI Inc. - Sponsored ADR (PONY) This Year?

The Transportation group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Pony AI Inc. - Sponsored ADR (PONY) been one of

Are Business Services Stocks Lagging  Charles River Associates (CRAI) This Year?
Are Business Services Stocks Lagging Charles River Associates (CRAI) This Year?

The Business Services group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. CRA International (CRAI) is a stock that can

Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year?
Is AIM ImmunoTech (AIM) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. AIM ImmunoTech Inc. (AIM) is a stock that can certainly grab the attention of many

Are Investors Undervaluing BlackRock TCP Capital (TCPC) Right Now?
Are Investors Undervaluing BlackRock TCP Capital (TCPC) Right Now?

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop

Why Cencora (COR) is a Top Value Stock for the Long-Term
Why Cencora (COR) is a Top Value Stock for the Long-Term

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

Here's Why AES (AES) is a Strong Value Stock
Here's Why AES (AES) is a Strong Value Stock

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

Should Value Investors Buy General Motors (GM) Stock?
Should Value Investors Buy General Motors (GM) Stock?

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With

Are Retail-Wholesale Stocks Lagging  Next (NXGPY) This Year?
Are Retail-Wholesale Stocks Lagging Next (NXGPY) This Year?

For those looking to find strong Retail-Wholesale stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Next PLC (NXGPY) one of those stocks right now? By

Are Investors Undervaluing Autoliv (ALV) Right Now?
Are Investors Undervaluing Autoliv (ALV) Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is Bragg Gaming Group Inc. (BRAG) Stock Outpacing Its Consumer Discretionary Peers This Year?
Is Bragg Gaming Group Inc. (BRAG) Stock Outpacing Its Consumer Discretionary Peers This Year?

For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Bragg Gaming Group Inc. (BRAG) is a stock that

Is Vita Coco Company (COCO) Outperforming Other Consumer Staples Stocks This Year?
Is Vita Coco Company (COCO) Outperforming Other Consumer Staples Stocks This Year?

For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Vita Coco Company, Inc. (COCO) one of those stocks

The Zacks Analyst Blog Highlights Micron Technology, Roche and UnitedHealth
The Zacks Analyst Blog Highlights Micron Technology, Roche and UnitedHealth

For Immediate Release

Chicago, IL – January 8, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Church & Dwight Accelerates Innovation to Defend Market Share
Church & Dwight Accelerates Innovation to Defend Market Share

Church & Dwight Co., Inc. (CHD) has been using product innovation as a key tool to defend market share in a competitive and promotion-heavy consumer environment. The company continues to rely on a

Zacks Industry Outlook Highlights Honeywell International, 3M, Grupo, Cibest and ITT
Zacks Industry Outlook Highlights Honeywell International, 3M, Grupo, Cibest and ITT

For Immediate Release

Chicago, IL – January 8, 2026 – Today, Zacks Equity Research discusses Honeywell International Inc. HON, 3M Co. MMM, Grupo Cibest S.A. CIB and ITT Inc. ITT.

Industry:

Zacks Industry Outlook Highlights Experian and Intertek Group
Zacks Industry Outlook Highlights Experian and Intertek Group

For Immediate Release

Chicago, IL – January 8, 2026 – Today, Zacks Equity Research discusses Experian plc EXPGY and Intertek Group plc IKTSY.

Industry: Business Information

Link: https://www.zacks.c

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

For Immediate Release

Chicago, IL – January 8, 2026 – Today, Zacks Equity Research discusses Soleno Therapeutics SLNO, Nektar Therapeutics NKTR, Rigel Pharmaceuticals RIGL, Ironwood Pharmaceuticals